HEADER IMMUNE SYSTEM 04-OCT-09 3K3Q TITLE CRYSTAL STRUCTURE OF A LLAMA ANTIBODY COMPLEXED WITH THE C. BOTULINUM TITLE 2 NEUROTOXIN SEROTYPE A CATALYTIC DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: LLAMA AA1 VHH DOMAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: BOTULINUM NEUROTOXIN TYPE A; COMPND 7 CHAIN: B; COMPND 8 FRAGMENT: N-TERMINAL FRAGMENT OF BONT CATALYTIC DOMAIN (RESIDUES 3- COMPND 9 250); COMPND 10 SYNONYM: BONT/A, BONTOXILYSIN-A, BOTOX, BOTULINUM NEUROTOXIN A LIGHT COMPND 11 CHAIN; COMPND 12 EC: 3.4.24.69; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: BOTULINUM NEUROTOXIN TYPE A; COMPND 16 CHAIN: C; COMPND 17 FRAGMENT: C-TERMINAL FRAGMENT OF BONT CATALYTIC DOMAIN (RESIDUES 251- COMPND 18 425); COMPND 19 SYNONYM: BONT/A, BONTOXILYSIN-A, BOTOX, BOTULINUM NEUROTOXIN A LIGHT COMPND 20 CHAIN; COMPND 21 EC: 3.4.24.69; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LAMA GLAMA; SOURCE 3 ORGANISM_TAXID: 9844; SOURCE 4 GENE: LLAMA VHH IMMUNOGLOBULIN; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET20B; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: CLOSTRIDIUM BOTULINUM A STR. HALL; SOURCE 12 ORGANISM_TAXID: 441771; SOURCE 13 GENE: BOTA, CBO0806, CLC_0862, NEUROTOXIN CATALYTIC DOMAIN; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: CLOSTRIDIUM BOTULINUM A STR. HALL; SOURCE 21 ORGANISM_TAXID: 441771; SOURCE 22 GENE: BOTA, CBO0806, CLC_0862, NEUROTOXIN CATALYTIC DOMAIN; SOURCE 23 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 24 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 25 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 26 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 27 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS LLAMA, VHH, ANTIBODY, BOTULINUM, NEUROTOXIN, BONT, CELL JUNCTION, KEYWDS 2 CELL MEMBRANE, CYTOPLASM, DISULFIDE BOND, HYDROLASE, MEMBRANE, KEYWDS 3 METAL-BINDING, METALLOPROTEASE, PHARMACEUTICAL, PROTEASE, SECRETED, KEYWDS 4 SYNAPSE, TOXIN, TRANSMEMBRANE, ZINC, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR A.A.THOMPSON,J.DONG,J.D.MARKS,R.C.STEVENS REVDAT 3 01-NOV-17 3K3Q 1 REMARK REVDAT 2 07-APR-10 3K3Q 1 JRNL REVDAT 1 23-FEB-10 3K3Q 0 JRNL AUTH J.DONG,A.A.THOMPSON,Y.FAN,J.LOU,F.CONRAD,M.HO,M.PIRES-ALVES, JRNL AUTH 2 B.A.WILSON,R.C.STEVENS,J.D.MARKS JRNL TITL A SINGLE-DOMAIN LLAMA ANTIBODY POTENTLY INHIBITS THE JRNL TITL 2 ENZYMATIC ACTIVITY OF BOTULINUM NEUROTOXIN BY BINDING TO THE JRNL TITL 3 NON-CATALYTIC ALPHA-EXOSITE BINDING REGION. JRNL REF J.MOL.BIOL. V. 397 1106 2010 JRNL REFN ISSN 0022-2836 JRNL PMID 20138889 JRNL DOI 10.1016/J.JMB.2010.01.070 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.4 REMARK 3 NUMBER OF REFLECTIONS : 21269 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.400 REMARK 3 FREE R VALUE TEST SET COUNT : 1029 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4287 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 1 REMARK 3 SOLVENT ATOMS : 70 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -13.24500 REMARK 3 B22 (A**2) : -1.28000 REMARK 3 B33 (A**2) : 14.52500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.48100 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM SIGMAA (A) : 0.48 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.48 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.469 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.565 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.992 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.157 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 20.54 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : CNS_TOPPAR:PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CNS_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : CNS_TOPPAR:ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3K3Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-OCT-09. REMARK 100 THE DEPOSITION ID IS D_1000055507. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-OCT-08 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL CRYO-COOLED REMARK 200 SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22641 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 2.800 REMARK 200 R MERGE (I) : 0.11700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.9 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.31400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.160 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% ETHYLENE GLYCOL, PH 7.0, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 84.14100 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.38200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 84.14100 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.38200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE IT IS POSSIBLE THAT A HEXAMER EXISTS IN REMARK 300 SOLUTION, BUT THIS WOULD BE IN EQUILIBRIUM WITH THE TRIMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 21780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 45440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -223.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -168.28200 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -95.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 ILE A 3 REMARK 465 ALA A 141 REMARK 465 ALA A 142 REMARK 465 ALA A 143 REMARK 465 LEU A 144 REMARK 465 GLU A 145 REMARK 465 HIS A 146 REMARK 465 HIS A 147 REMARK 465 HIS A 148 REMARK 465 HIS A 149 REMARK 465 HIS A 150 REMARK 465 HIS A 151 REMARK 465 MET B -1 REMARK 465 ALA B 0 REMARK 465 VAL B 1 REMARK 465 LEU B 200 REMARK 465 GLU B 201 REMARK 465 VAL B 202 REMARK 465 ASP B 203 REMARK 465 THR B 204 REMARK 465 ASN B 205 REMARK 465 PRO B 206 REMARK 465 LEU B 207 REMARK 465 LEU B 208 REMARK 465 GLY B 209 REMARK 465 ALA B 210 REMARK 465 TYR C 251 REMARK 465 GLU C 252 REMARK 465 ASN C 418 REMARK 465 PHE C 419 REMARK 465 THR C 420 REMARK 465 GLY C 421 REMARK 465 LEU C 422 REMARK 465 PHE C 423 REMARK 465 GLU C 424 REMARK 465 PHE C 425 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 32 40.96 38.14 REMARK 500 ASP A 33 46.23 -104.01 REMARK 500 THR A 44 42.55 -106.91 REMARK 500 ALA A 45 147.52 -173.28 REMARK 500 VAL A 62 -72.78 -113.63 REMARK 500 GLU A 76 -37.27 -29.85 REMARK 500 LEU A 78 31.61 -148.08 REMARK 500 ARG A 81 -2.54 -161.50 REMARK 500 ALA A 88 -35.17 -38.66 REMARK 500 ALA A 90 55.41 76.75 REMARK 500 THR A 91 12.79 -148.20 REMARK 500 ALA A 97 138.53 -171.60 REMARK 500 THR A 105 113.59 -35.88 REMARK 500 ALA A 106 -175.18 175.89 REMARK 500 SER A 139 -157.77 -131.01 REMARK 500 LYS B 6 172.39 -57.91 REMARK 500 TYR B 10 -44.43 -29.65 REMARK 500 ASN B 15 -1.96 -140.90 REMARK 500 ASN B 26 27.74 -75.54 REMARK 500 ASP B 49 84.18 -64.92 REMARK 500 PHE B 51 -20.06 -140.84 REMARK 500 GLU B 56 -153.32 -103.96 REMARK 500 PRO B 62 177.03 -56.42 REMARK 500 GLU B 64 -90.69 -100.95 REMARK 500 GLN B 67 49.76 -65.68 REMARK 500 SER B 71 132.06 -174.10 REMARK 500 ASP B 74 117.37 179.10 REMARK 500 SER B 100 0.83 -57.97 REMARK 500 SER B 143 -162.97 -69.42 REMARK 500 TYR B 144 135.97 -176.23 REMARK 500 SER B 157 -148.48 -85.23 REMARK 500 SER B 167 134.96 -176.58 REMARK 500 VAL B 172 -73.04 -91.11 REMARK 500 THR C 306 1.46 87.62 REMARK 500 THR C 307 -79.41 -49.40 REMARK 500 ALA C 308 -155.39 -144.55 REMARK 500 ASN C 377 88.24 -164.20 REMARK 500 ASN C 410 -19.99 -49.18 REMARK 500 PHE C 413 73.65 -152.24 REMARK 500 LEU C 416 -156.30 -105.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 251 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 223 NE2 REMARK 620 2 HIS B 227 NE2 95.6 REMARK 620 3 GLU C 262 OE1 85.2 96.3 REMARK 620 4 GLU C 262 OE2 143.3 96.7 59.2 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 251 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THERE IS A VAL -> ALA NATURAL VARIANT AT RESIDUE 27. DBREF 3K3Q B 3 250 UNP A5HZZ9 BXA1_CLOBH 3 250 DBREF 3K3Q C 251 425 UNP A5HZZ9 BXA1_CLOBH 251 425 DBREF 3K3Q A 1 151 PDB 3K3Q 3K3Q 1 151 SEQADV 3K3Q MET B -1 UNP A5HZZ9 EXPRESSION TAG SEQADV 3K3Q ALA B 0 UNP A5HZZ9 EXPRESSION TAG SEQADV 3K3Q VAL B 1 UNP A5HZZ9 EXPRESSION TAG SEQADV 3K3Q GLN B 2 UNP A5HZZ9 EXPRESSION TAG SEQADV 3K3Q VAL B 27 UNP A5HZZ9 ALA 27 SEE REMARK 999 SEQRES 1 A 151 MET ASP ILE ALA VAL GLN LEU VAL ASP SER GLY GLY GLY SEQRES 2 A 151 THR LEU GLN ALA GLY LYS SER LEU ARG LEU SER CYS ALA SEQRES 3 A 151 ILE SER GLY LEU ALA PHE ASP GLY GLY ALA MET GLY SER SEQRES 4 A 151 GLU HIS ARG LEU THR ALA GLY ALA MET GLY TRP PHE ARG SEQRES 5 A 151 GLN ALA PRO GLY LYS ASP ARG GLU PHE VAL ALA ALA ILE SEQRES 6 A 151 SER PRO ARG THR ASP GLU THR TYR TYR ALA GLU SER LEU SEQRES 7 A 151 GLU GLY ARG PHE SER VAL SER ARG ASP ALA ALA ALA THR SEQRES 8 A 151 MET VAL PHE LEU GLN ALA ASP ASN VAL ARG LEU ASP ASP SEQRES 9 A 151 THR ALA SER TYR TYR CYS ALA ALA ASP GLU ASP VAL THR SEQRES 10 A 151 PRO ARG VAL MET GLY VAL ILE PRO HIS ALA ASP HIS TRP SEQRES 11 A 151 GLY GLN GLY THR LEU VAL THR VAL SER SER ALA ALA ALA SEQRES 12 A 151 LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 B 252 MET ALA VAL GLN PHE VAL ASN LYS GLN PHE ASN TYR LYS SEQRES 2 B 252 ASP PRO VAL ASN GLY VAL ASP ILE ALA TYR ILE LYS ILE SEQRES 3 B 252 PRO ASN VAL GLY GLN MET GLN PRO VAL LYS ALA PHE LYS SEQRES 4 B 252 ILE HIS ASN LYS ILE TRP VAL ILE PRO GLU ARG ASP THR SEQRES 5 B 252 PHE THR ASN PRO GLU GLU GLY ASP LEU ASN PRO PRO PRO SEQRES 6 B 252 GLU ALA LYS GLN VAL PRO VAL SER TYR TYR ASP SER THR SEQRES 7 B 252 TYR LEU SER THR ASP ASN GLU LYS ASP ASN TYR LEU LYS SEQRES 8 B 252 GLY VAL THR LYS LEU PHE GLU ARG ILE TYR SER THR ASP SEQRES 9 B 252 LEU GLY ARG MET LEU LEU THR SER ILE VAL ARG GLY ILE SEQRES 10 B 252 PRO PHE TRP GLY GLY SER THR ILE ASP THR GLU LEU LYS SEQRES 11 B 252 VAL ILE ASP THR ASN CYS ILE ASN VAL ILE GLN PRO ASP SEQRES 12 B 252 GLY SER TYR ARG SER GLU GLU LEU ASN LEU VAL ILE ILE SEQRES 13 B 252 GLY PRO SER ALA ASP ILE ILE GLN PHE GLU CYS LYS SER SEQRES 14 B 252 PHE GLY HIS GLU VAL LEU ASN LEU THR ARG ASN GLY TYR SEQRES 15 B 252 GLY SER THR GLN TYR ILE ARG PHE SER PRO ASP PHE THR SEQRES 16 B 252 PHE GLY PHE GLU GLU SER LEU GLU VAL ASP THR ASN PRO SEQRES 17 B 252 LEU LEU GLY ALA GLY LYS PHE ALA THR ASP PRO ALA VAL SEQRES 18 B 252 THR LEU ALA HIS GLU LEU ILE HIS ALA GLY HIS ARG LEU SEQRES 19 B 252 TYR GLY ILE ALA ILE ASN PRO ASN ARG VAL PHE LYS VAL SEQRES 20 B 252 ASN THR ASN ALA TYR SEQRES 1 C 175 TYR GLU MET SER GLY LEU GLU VAL SER PHE GLU GLU LEU SEQRES 2 C 175 ARG THR PHE GLY GLY HIS ASP ALA LYS PHE ILE ASP SER SEQRES 3 C 175 LEU GLN GLU ASN GLU PHE ARG LEU TYR TYR TYR ASN LYS SEQRES 4 C 175 PHE LYS ASP ILE ALA SER THR LEU ASN LYS ALA LYS SER SEQRES 5 C 175 ILE VAL GLY THR THR ALA SER LEU GLN TYR MET LYS ASN SEQRES 6 C 175 VAL PHE LYS GLU LYS TYR LEU LEU SER GLU ASP THR SER SEQRES 7 C 175 GLY LYS PHE SER VAL ASP LYS LEU LYS PHE ASP LYS LEU SEQRES 8 C 175 TYR LYS MET LEU THR GLU ILE TYR THR GLU ASP ASN PHE SEQRES 9 C 175 VAL LYS PHE PHE LYS VAL LEU ASN ARG LYS THR TYR LEU SEQRES 10 C 175 ASN PHE ASP LYS ALA VAL PHE LYS ILE ASN ILE VAL PRO SEQRES 11 C 175 LYS VAL ASN TYR THR ILE TYR ASP GLY PHE ASN LEU ARG SEQRES 12 C 175 ASN THR ASN LEU ALA ALA ASN PHE ASN GLY GLN ASN THR SEQRES 13 C 175 GLU ILE ASN ASN MET ASN PHE THR LYS LEU LYS ASN PHE SEQRES 14 C 175 THR GLY LEU PHE GLU PHE HET ZN B 251 1 HETNAM ZN ZINC ION FORMUL 4 ZN ZN 2+ FORMUL 5 HOH *70(H2 O) HELIX 1 1 GLY A 38 ARG A 42 5 5 HELIX 2 2 GLU A 76 GLU A 79 5 4 HELIX 3 3 THR A 117 ILE A 124 1 8 HELIX 4 4 ILE B 24 GLY B 28 5 5 HELIX 5 5 THR B 80 SER B 100 1 21 HELIX 6 6 THR B 101 GLY B 114 1 14 HELIX 7 7 ILE B 130 THR B 132 5 3 HELIX 8 8 ASP B 216 TYR B 233 1 18 HELIX 9 9 PHE C 260 GLY C 267 1 8 HELIX 10 10 GLY C 268 ILE C 274 5 7 HELIX 11 11 ASP C 275 ALA C 300 1 26 HELIX 12 12 SER C 309 TYR C 321 1 13 HELIX 13 13 ASP C 334 GLU C 347 1 14 HELIX 14 14 THR C 350 LYS C 359 1 10 HELIX 15 15 PHE C 401 ASN C 405 5 5 HELIX 16 16 ASN C 409 PHE C 413 5 5 SHEET 1 A 4 GLN A 6 SER A 10 0 SHEET 2 A 4 LEU A 21 SER A 28 -1 O SER A 28 N GLN A 6 SHEET 3 A 4 MET A 92 ALA A 97 -1 O LEU A 95 N LEU A 23 SHEET 4 A 4 SER A 83 ARG A 86 -1 N SER A 85 O PHE A 94 SHEET 1 B 6 GLY A 13 GLN A 16 0 SHEET 2 B 6 THR A 134 SER A 139 1 O LEU A 135 N GLY A 13 SHEET 3 B 6 ALA A 106 ASP A 113 -1 N TYR A 108 O THR A 134 SHEET 4 B 6 ALA A 47 GLN A 53 -1 N PHE A 51 O TYR A 109 SHEET 5 B 6 ARG A 59 ILE A 65 -1 O ILE A 65 N MET A 48 SHEET 6 B 6 THR A 72 TYR A 74 -1 O TYR A 73 N ALA A 64 SHEET 1 C 4 GLY A 13 GLN A 16 0 SHEET 2 C 4 THR A 134 SER A 139 1 O LEU A 135 N GLY A 13 SHEET 3 C 4 ALA A 106 ASP A 113 -1 N TYR A 108 O THR A 134 SHEET 4 C 4 HIS A 129 TRP A 130 -1 O HIS A 129 N ALA A 112 SHEET 1 D 8 TYR B 144 GLU B 148 0 SHEET 2 D 8 CYS B 134 ILE B 138 -1 N ILE B 135 O GLU B 147 SHEET 3 D 8 ILE B 19 LYS B 23 -1 N LYS B 23 O ASN B 136 SHEET 4 D 8 VAL B 33 HIS B 39 -1 O ALA B 35 N ALA B 20 SHEET 5 D 8 ILE B 42 ARG B 48 -1 O VAL B 44 N PHE B 36 SHEET 6 D 8 LEU B 151 GLY B 155 1 O ILE B 153 N ILE B 45 SHEET 7 D 8 GLN B 184 ARG B 187 1 O ILE B 186 N ILE B 154 SHEET 8 D 8 GLU B 164 SER B 167 -1 N GLU B 164 O ARG B 187 SHEET 1 E 2 GLU B 126 LEU B 127 0 SHEET 2 E 2 SER C 302 ILE C 303 1 O SER C 302 N LEU B 127 SHEET 1 F 4 LYS B 212 ALA B 214 0 SHEET 2 F 4 PHE B 192 GLU B 197 -1 N PHE B 196 O PHE B 213 SHEET 3 F 4 VAL C 373 LYS C 375 -1 O PHE C 374 N THR B 193 SHEET 4 F 4 THR C 414 LYS C 415 -1 O THR C 414 N LYS C 375 SHEET 1 G 2 VAL B 242 ASN B 246 0 SHEET 2 G 2 GLY C 255 SER C 259 -1 O LEU C 256 N VAL B 245 SHEET 1 H 2 SER C 324 GLU C 325 0 SHEET 2 H 2 PHE C 331 SER C 332 -1 O SER C 332 N SER C 324 SSBOND 1 CYS A 25 CYS A 110 1555 1555 2.04 LINK NE2 HIS B 223 ZN ZN B 251 1555 1555 2.02 LINK NE2 HIS B 227 ZN ZN B 251 1555 1555 2.13 LINK OE1 GLU C 262 ZN ZN B 251 1555 1555 1.89 LINK OE2 GLU C 262 ZN ZN B 251 1555 1555 2.45 CISPEP 1 ILE A 124 PRO A 125 0 4.07 SITE 1 AC1 4 HIS B 223 HIS B 227 TYR B 250 GLU C 262 CRYST1 168.282 48.764 103.643 90.00 116.75 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005942 0.000000 0.002995 0.00000 SCALE2 0.000000 0.020507 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010805 0.00000 MASTER 360 0 1 16 32 0 1 6 0 0 0 46 END